Literature DB >> 10582596

Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels.

S E Wolfe1, S J Morris.   

Abstract

The dopamine D2 receptor belongs to the serpentine superfamily of receptors, which have seven transmembrane segments and activate G proteins. D2 receptors are known to be linked, through Galpha(o)- and Galpha(i)-containing G proteins, to several signaling pathways in neuronal and secretory cells, including inhibition of adenylyl cyclase and high voltage-activated Ca2+ channels (HVA-CCs). The dopamine D2 receptor exists in two alternatively spliced isoforms, "long" and "short" (D2L, and D2S, respectively), which have identical ligand binding sites but differ by 29 amino acids in the third intracellular loop, the proposed site for G protein interaction. This has led to the speculation that the two isoforms may interact with different G proteins. We have transfected the AtT20 cell line with either D2L (KCL line) or D2S (KCS line) to facilitate experimentation on the individual isoforms. Both lines show dopamine agonist-dependent inhibition of Q-type HVA-CCs. We combined G protein antisense knock-down studies with multiwavelength fluorescence video microscopy to measure changes in HVA-CC inhibition to investigate the possibility of differential G protein coupling to this inhibition. The initial, rapid, K+ depolarization-induced increase in intracellular Ca2+ concentration is due to influx through HVA-CCs. Our studies reveal that both D2 isoforms couple to Galpha(o) to partially inhibit this influx. However, D2L also couples to Galpha(i)3, whereas D2S couples to Galpha(i)2. These data support the hypothesis of differential coupling of D2 receptor isoforms to G proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582596     DOI: 10.1046/j.1471-4159.1999.0732375.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Dopamine receptor subtypes in the native human heart.

Authors:  Carlo Cavallotti; Massimo Mancone; Paolo Bruzzone; Maurizio Sabbatini; Fiorenzo Mignini
Journal:  Heart Vessels       Date:  2010-09       Impact factor: 2.037

2.  Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas.

Authors:  Zhipeng Su; Chengde Wang; Jinsen Wu; Xiaolong Jiang; Yunxiang Chen; Yong Chen; Weiming Zheng; Qichuan Zhuge; Zhebao Wu; Yanjun Zeng
Journal:  Neurol Sci       Date:  2011-07-12       Impact factor: 3.307

Review 3.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

4.  Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells.

Authors:  Zhipeng Su; Xiaolong Jiang; Chengde Wang; Jie Liu; Yunxiang Chen; Qun Li; Jinsen Wu; Weiming Zheng; Qichuan Zhuge; Kunlin Jin; Zhebao Wu
Journal:  Endocrine       Date:  2012-06-09       Impact factor: 3.633

Review 5.  Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective.

Authors:  Jillian S Weissenrieder; Jeffrey D Neighbors; Richard B Mailman; Raymond J Hohl
Journal:  J Pharmacol Exp Ther       Date:  2019-04-18       Impact factor: 4.030

6.  The histamine autoreceptor is a short isoform of the H₃ receptor.

Authors:  F Gbahou; A Rouleau; J-M Arrang
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

7.  Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.

Authors:  Souichi Oomizu; Nadka Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455

8.  The familial hemiplegic migraine mutation R192Q reduces G-protein-mediated inhibition of P/Q-type (Ca(V)2.1) calcium channels expressed in human embryonic kidney cells.

Authors:  Karim Melliti; Manfred Grabner; Guy R Seabrook
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

9.  Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the prolactinomas and gonadotrope tumors.

Authors:  Zhe Bao Wu; Chu Zhong Li; Xu Yi Zong; Zhi Peng Su; Yan Jun Zeng; Ya Zhuo Zhang
Journal:  J Neurooncol       Date:  2009-02-28       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.